quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:00:00·1998d
PRRelease
Rexahn Pharmaceuticals, Inc. logo

Rexahn Pharmaceuticals Announces Stockholder Approval of All Proposals Required for Merger with Ocuphire Pharma

REXN· Rexahn Pharmaceuticals, Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • REXN
    Rexahn Pharmaceuticals, Inc.
    Health Care

Related

  • NEWS1123d
    MaxCyte Appoints Douglas Swirsky As Chief Financial Officer
  • PR1123d
    MaxCyte Appoints Douglas Swirsky as Chief Financial Officer
  • PR1995d
    Rexahn Pharmaceuticals Announces Expected Effectiveness of Reverse Stock Split and Merger Transaction with Ocuphire Pharma
  • PR2016d
    SHAREHOLDER ALERT: WeissLaw LLP Reminds EIDX, REXN, and WPX Shareholders About Its Ongoing Investigations
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022